Ferrari M

No ORCID on file · 2 papers in corpus · active 2019-2021
2021
PROCEEDINGS OF THE ANNUAL CONGRESS OF SIAPec IAP : November 23rd-27th, 2021
Pathologica
2019
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis.
EBioMedicine ·doi:10.1016/j.ebiom.2018.11.045

BackgroundInflammatory mediator prostaglandin E2-prostaglandin E2 receptor EP3 (PTGER3) signaling is critical for tumor-associated angiogenesis, tumor growth, and chemoresistance. However, the mechanism underlying these effects in ovarian c…